ANATOMICAL PATHOLOGY| Volume 55, ISSUE 3, P375-382, April 2023

Download started.


Clinicopathological spectrums and prognosis of primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and low-grade appendiceal mucinous neoplasms

Published:October 28, 2022DOI:


      Primary appendiceal adenocarcinoma (APCA), goblet cell adenocarcinoma (GCA), and low/high-grade appendiceal mucinous neoplasms (LAMN/HAMN) are distinct entities with overlapping clinical presentation and histomorphology, leading to diagnostic challenges. We retrospectively reviewed our archived cases between 2010 and 2018 for diagnosis reappraisal and comparative analysis using updated terminology and modern parameters. A total of 87 cases (22 APCA, 40 GCA, and 25 LAMN pT≥3) were included. The entire cohort had 49 women and 38 men with a median age of 59.9 (range 26–88) years. There were no statistically significant differences in age and sex among the three groups. Clinically, patients with GCA were more likely to present with acute appendicitis (65%) and more likely to have appendectomy as initial surgery (68%). Both APCA and GCA were more likely to involve the proximal appendix while LAMN was more likely to involve the distal appendix (p<0.05). All APCAs were associated with mucosal precursor lesions, most commonly tubular, tubulovillous, or villous adenoma, flat LAMN/HAMN-pTis mucinous epithelium, or mixed, which correlated with distinct histomorphology, tumour differentiation, and stage. Although polypoid precursor lesions were rare in GCA, a significant proportion of GCA showed crypt atypia associated with neoplastic cells. Immunohistochemically, APCA had more frequent β-catenin nuclear positivity and loss of SATB2 expression (p<0.05). KRAS mutation was more common in APCA than in GCA (8/11 vs 1/7, p<0.01). We further validated the three-tiered grading system (G1, G2, G3) in GCA, which correlated well with tumour stage and patient survival. APCA had worse progression-free and disease-specific survivals than GCA and LAMN (pT≥3) with the latter being relatively indolent even when perforated with peritoneal spread. Our study is the first comprehensive comparison between all three appendiceal neoplasms. We also describe a spectrum of previously under-recognised crypt atypia in GCA, which should trigger a diligent search for GCA if present.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Pathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • WHO Classification of Tumours Editorial Board
        World Health Organization Classification of Tumours. Digestive System Tumours.
        5th ed. IARC Press, Lyon2019 (Chapters 135–56)
        • Bradley R.F.
        • Stewart JHt
        • Russell G.B.
        • Levine E.A.
        • Geisinger K.R.
        Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.
        Am J Surg Pathol. 2006; 30: 551-559
        • Carr N.J.
        • Bibeau F.
        • Bradley R.F.
        • et al.
        The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei.
        Histopathology. 2017; 71: 847-858
        • Burke A.P.
        • Sobin L.H.
        • Federspiel B.H.
        • Shekitka K.M.
        • Helwig E.B.
        Goblet cell carcinoids and related tumors of the vermiform appendix.
        Am J Clin Pathol. 1990; 94: 27-35
        • Tang L.H.
        • Shia J.
        • Soslow R.A.
        • et al.
        Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix.
        Am J Surg Pathol. 2008; 32: 1429-1443
        • Yozu M.
        • Johncilla M.E.
        • Srivastava A.
        • et al.
        Histologic and outcome study supports reclassifying appendiceal goblet cell carcinoids as goblet cell adenocarcinomas, and grading and staging similarly to colonic adenocarcinomas.
        Am J Surg Pathol. 2018; 42: 898-910
        • Isaacson P.
        Crypt cell carcinoma of the appendix (so-called adenocarcinoid tumor).
        Am J Surg Pathol. 1981; 5: 213-224
        • Goddard M.J.
        • Lonsdale R.N.
        The histogenesis of appendiceal carcinoid tumours.
        Histopathology. 1992; 20: 345-349
        • Clevers H.
        The intestinal crypt, a prototype stem cell compartment.
        Cell. 2013; 154: 274-284
        • Bhattacharya I.
        • Barman N.
        • Maiti M.
        • Sarkar R.
        Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma.
        Med Pharm Rep. 2019; 92: 246-252
        • Yadamsuren E.A.
        • Nagy S.
        • Pajor L.
        • Lacza A.
        • Bogner B.
        Characteristics of advanced- and non advanced sporadic polypoid colorectal adenomas: correlation to KRAS mutations.
        Pathol Oncol Res. 2012; 18: 1077-1084
        • Li X.
        • Sun K.
        • Liao X.
        • Gao H.
        • Zhu H.
        • Xu R.
        Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
        BMC Cancer. 2020; 20: 400
        • Zhu X.
        • Salhab M.
        • Tomaszewicz K.
        • et al.
        Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
        Hum Pathol. 2019; 85: 260-269
        • Mikaeel R.R.
        • Young J.P.
        • Tapia Rico G.
        • et al.
        Immunohistochemistry features and molecular pathology of appendiceal neoplasms.
        Crit Rev Clin Lab Sci. 2021; 58: 369-384
        • Liao X.
        • Vavinskaya V.
        • Sun K.
        • et al.
        Mutation profile of high-grade appendiceal mucinous neoplasm.
        Histopathology. 2020; 76: 461-469
        • Wen K.W.
        • Grenert J.P.
        • Joseph N.M.
        • et al.
        Genomic profile of appendiceal goblet cell carcinoid is distinct compared to appendiceal neuroendocrine tumor and conventional adenocarcinoma.
        Hum Pathol. 2018; 77: 166-174
        • Ritterhouse L.L.
        • Wu E.Y.
        • Kim W.G.
        • et al.
        Loss of SMAD4 protein expression in gastrointestinal and extra-gastrointestinal carcinomas.
        Histopathology. 2019; 75: 546-551
        • Jesinghaus M.
        • Konukiewitz B.
        • Foersch S.
        • et al.
        Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix.
        Mod Pathol. 2018; 31: 829-839
        • Johncilla M.
        • Stachler M.
        • Misdraji J.
        • et al.
        Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas.
        Mod Pathol. 2018; 31: 989-996
        • Moh M.
        • Krings G.
        • Ates D.
        • Aysal A.
        • Kim G.E.
        • Rabban J.T.
        SATB2 expression distinguishes ovarian metastases of colorectal and appendiceal origin from primary ovarian tumors of mucinous or endometrioid type.
        Am J Surg Pathol. 2016; 40: 419-432
        • Yang C.
        • Sun L.
        • Zhang L.
        • et al.
        SATB2 shows different profiles between appendiceal adenocarcinomas ex goblet cell carcinoids and appendiceal/colorectal conventional adenocarcinomas: an immunohistochemical study with comparison to CDX2.
        Gastroenterol Res. 2018; 11: 221-230
        • Taggart M.W.
        • Galbincea J.
        • Mansfield P.F.
        • et al.
        High-level microsatellite instability in appendiceal carcinomas.
        Am J Surg Pathol. 2013; 37: 1192-1200
        • Hara K.
        • Saito T.
        • Hayashi T.
        • et al.
        A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
        Pathol Res Pract. 2015; 211: 657-664
        • Dimmler A.
        • Geddert H.
        • Faller G.
        EGFR, KRAS, BRAF-mutations and microsatellite instability are absent in goblet cell carcinoids of the appendix.
        Pathol Res Pract. 2014; 210: 274-278
        • Arai H.
        • Baca Y.
        • Battaglin F.
        • et al.
        Molecular characterization of appendiceal goblet cell carcinoid.
        Mol Cancer Ther. 2020; 19: 2634-2640
        • Kelly K.J.
        Management of appendix cancer.
        Clin Colon Rectal Surg. 2015; 28: 247-255
        • Garland-Kledzik M.
        • Scholer A.
        • Ensenyat-Mendez M.
        • et al.
        Establishing novel molecular subtypes of appendiceal cancer.
        Ann Surg Oncol. 2022; 29: 2118-2125